100 related articles for article (PubMed ID: 25730617)
1. Biological response modifiers in the treatment of noninfectious uveitis.
Kopplin LJ; Shifera AS; Suhler EB; Lin P
Int Ophthalmol Clin; 2015; 55(2):19-36. PubMed ID: 25730617
[No Abstract] [Full Text] [Related]
2. [Hyper-IGE reactions in uveitis and their immunomodulation with cytokine-containing agents].
Teplinskaia LE; Filichkina NS
Vestn Oftalmol; 2006; 122(6):33-5. PubMed ID: 17217200
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor necrosis factor-α agents in noninfectious uveitis.
Gueudry J; LeHoang P; Bodaghi B
Dev Ophthalmol; 2012; 51():63-78. PubMed ID: 22517205
[TBL] [Abstract][Full Text] [Related]
4. [The prospects of the biotherapy for refractory uveitis].
Zheng YZ
Zhonghua Yan Ke Za Zhi; 2016 Jul; 52(7):551-6. PubMed ID: 27531117
[TBL] [Abstract][Full Text] [Related]
5. [Immunologic disorders in endogenous uveitis and the possible means of their correction by drugs].
Vanichkin AA; Shpak NI
Oftalmol Zh; 1982; 37(1):10-3. PubMed ID: 6979018
[No Abstract] [Full Text] [Related]
6. Rituximab for noninfectious uveitis.
Miserocchi E; Modorati G
Dev Ophthalmol; 2012; 51():98-109. PubMed ID: 22517208
[TBL] [Abstract][Full Text] [Related]
7. [Efficiency of treatment of uveitis with the drug superlymph].
Teplinskaia LE; Filichkina NS; Matevosova KS
Vestn Oftalmol; 2005; 121(4):22-6. PubMed ID: 16223038
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of posterior noninfectious uveitis : Current situation and future developments].
Pleyer U; Pohlmann D; Stübiger N
Ophthalmologe; 2016 May; 113(5):380-90. PubMed ID: 27165275
[TBL] [Abstract][Full Text] [Related]
9. Interferon-α therapy in noninfectious uveitis.
Deuter C; Stübiger N; Zierhut M
Dev Ophthalmol; 2012; 51():90-7. PubMed ID: 22517207
[TBL] [Abstract][Full Text] [Related]
10. New Immunosuppressive Therapies in Uveitis Treatment.
Mérida S; Palacios E; Navea A; Bosch-Morell F
Int J Mol Sci; 2015 Aug; 16(8):18778-95. PubMed ID: 26270662
[TBL] [Abstract][Full Text] [Related]
11. Treatment strategies for childhood noninfectious chronic uveitis: an update.
Cantarini L; Simonini G; Frediani B; Pagnini I; Galeazzi M; Cimaz R
Expert Opin Investig Drugs; 2012 Jan; 21(1):1-6. PubMed ID: 22074394
[TBL] [Abstract][Full Text] [Related]
12. Immunologic insights into uveitis and retinitis: the immunoregulatory circuit.
Kaplan HJ; Waldrep JC
Ophthalmology; 1984 Jun; 91(6):655-65. PubMed ID: 6611528
[TBL] [Abstract][Full Text] [Related]
13. Treatment of noninfectious uveitis.
Ferreira LB; Farrall AL; Furtado JM; Smith JR
Arq Bras Oftalmol; 2021; 84(6):610-621. PubMed ID: 34431877
[TBL] [Abstract][Full Text] [Related]
14. Possible molecular mechanisms to account for the efficacy of allopurinol against experimental autoimmune uveitis.
Namazi MR
Int Immunopharmacol; 2004 Jan; 4(1):161-2. PubMed ID: 14975372
[No Abstract] [Full Text] [Related]
15. New biologic drugs: anti-interleukin therapy.
Tappeiner C; Möller B; Hennig M; Heiligenhaus A
Dev Ophthalmol; 2012; 51():79-89. PubMed ID: 22517206
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the effect of treatment with FIBS preparation on the clinical state and various parameters of the immune system in patients with uveitis].
Puchalska-Niedbał L
Ann Acad Med Stetin; 1989; 35():179-88. PubMed ID: 2639596
[TBL] [Abstract][Full Text] [Related]
17. [T and B lymphocytes in aqueous humor and peripheral blood in patients with uveitis].
Smecka Z; Svec V; Matousková I
Cesk Oftalmol; 1986 Feb; 42(1):39-42. PubMed ID: 3485477
[No Abstract] [Full Text] [Related]
18. [Various lymphocytic (B, T, suppressor and helper) sub-populations in uveitis].
Secchi AG; Tremolada F; Malacarne N; Angi MR
Bull Mem Soc Fr Ophtalmol; 1980; 92():320-4. PubMed ID: 6452923
[No Abstract] [Full Text] [Related]
19. New treatment options for noninfectious uveitis.
Gomes Bittencourt M; Sepah YJ; Do DV; Agbedia O; Akhtar A; Liu H; Akhlaq A; Annam R; Ibrahim M; Nguyen QD
Dev Ophthalmol; 2012; 51():134-61. PubMed ID: 22517211
[TBL] [Abstract][Full Text] [Related]
20. [Cellular and humoral immunity in uveitis].
Dernouchamps JP
J Fr Ophtalmol; 1979 Apr; 2(4):297-309. PubMed ID: 314951
[No Abstract] [Full Text] [Related]
[Next] [New Search]
